Acetaminophen

Perrigo Confirms Settlement Of Generic Version Of Ofirmev Injection Patent LitigationAllegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev (acetaminophen) injection brought by Cadence Pharmaceuticals Inc.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen